Genesis

Tag: Genesis Business Humanity Club

  • Genesis Business Humanity Club Announce October 26th Event to Raise Immediate Funds for the People of Israel

    Genesis Business Humanity Club Announce October 26th Event to Raise Immediate Funds for the People of Israel

    • Event will take place at Red South Beach in Miami
    • Yaakov Zada-Daniel, Star of Netflix Hit Series Fauda, to share his life story as an orphan growing up in Israel
    • Israel Consul General Maor Elbaz-Starinsky will also address the audience

    October 13, 2023; Miami Beach, Florida; Tel Aviv Israel – Genesis Business Humanity Club, a private network including business and philanthropic leaders who identify meaningful technologies emanating from Israel and bringing those technologies to the United States, today announced they are hosting a fund-raising event at Red South Beach steakhouse on October 26.

    The event will benefit orphans, widows, children, and families in Israel, in partnership with Simcha Connections and other organizations. Sponsors and attendees will have the opportunity to hear from special guest Yaakov Zada-Daniel, from the hit show Fauda, himself an orphan who has established an orphanage in Israel.

    Additionally, Consul General Maor Elbaz-Starinsky will be in attendance.  Elbaz-Starinsky leads the Miami Consulate of Israel and works together with influential Jewish and Israeli communities in Florida to promote interfaith cooperation to combat antisemitism and racism.

    “This will be a very special event that brings together the Miami community in support of orphans, children, and families in Israel in the wake of the horrific massacre,” said Amiel Aviman, co-founder and CEO of Genesis Business Humanity based in Miami.

    “Attending this event will raise funds and awareness around the opportunity to ensure orphaned children, widows, and families in Israel will have access to resources and can set out on a path for a successful life of joy and promise,” said Ranny Yarom, co-founder and CEO of Genesis Business Humanity based in Israel.

    Yarom is leading all projects on the ground in Israel, working with community leaders and the IDF (as a retired Colonel and entrepreneur), and ensuring resources go directly to those most affected by the brutality and destruction near the Gaza border.

    For event information and tickets, please visit this page.

    ABOUT GENESIS BUSINESS HUMANITY

    Genesis Club members are part of an exclusive network of industry leaders and entrepreneurs committed to supporting businesses who share our mission to serve humanity. The Genesis Club has developed a new economic framework which balances financial, social, environmental, and human capital, and electrifies innovation and success.

    Learn more at https://genesisbh.net/

    MEDIA INQUIRES:

    Cynthia Artin

    Genesis Digital

    info@genesisbh.net   

  • Member Spotlight: Elior Peles Bring Scientific and Academic Experience and Excellence to the Club

    Member Spotlight: Elior Peles Bring Scientific and Academic Experience and Excellence to the Club

    Elior Peles, respected researcher, teacher, and author, was one of the early Members of the Genesis Business Humanity Club and is a perfect example of what makes our global group different and effective.

    As founder and leader of the Peles Lab at the Weizmann Institute of Science in Israel, Elior received his BSc and MSc degrees in biology from the Hebrew University of Jerusalem. After completing his studies towards a PhD in biochemistry at the Weizmann Institute of Science, Elior moved to California to take a Group Leader position at Sugen Inc. in California.

    Sugen went public in October 1994, and in 1997 filed its first Investigational New Drug (IND) application, for a PDGFR inhibitor. SU5416 (Semaxanib) and SU6668 went into clinical trials for colon cancer in 1999. SU5416 proceeded to Phase 3 trials, while the follow-on compound, SU11248 (Sunitinib) was later approved for human use, and a related compound SU11654 (Toceranib) was approved for canine tumors.

    Sugen was acquired by Pharmacia & Upjohn in 1999 in a stock swap valued at $650 million, and in December 1999, Pharmacia & Upjohn merged with Monsanto. The company was renamed Pharmacia in 2002. Pharmacia was then acquired by Pfizer in April 2003.

    In 1997, Elior returned to the Department of Molecular Cell Biology at the Weizmann Institute of Science.  He headed this department from 2010-2014 and served as the Dean of the Faculty of Biology from 2014-2021.

    He is the incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience. His lab studies the molecular mechanisms underlying axon-glia interactions and myelination by Schwann cells and oligodendrocytes.

    The Peles Lab today is continuing research on Myelin, an insulating membrane sheath produced by specialized glial cells; Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS). It enables fast and efficient nerve conduction and provides essential trophic support to maintain axonal integrity and survival.

    Destruction of myelin leads to several neurological diseases such as multiple sclerosis and is also associated with psychiatric and neurodegenerative disorders. Our lab combines molecular, biochemical, and advanced light and electron microscopy techniques to study the various aspects of myelinating glial cells and the mechanisms that enable them to form one of the most complex structures found in nature.

    Three projects include:

    Axon-glia Communication

    The formation and maintenance of myelinated nerve fibers requires reciprocal communication between Schwann cells or oligodendrocytes with their associated axons.  We are using various molecular approaches to identify the axonal signals that enable Schwann cells and oligodendrocytes to ensheath the axons they contact and to myelinate them.

    PNS and CNS myelination

    Myelinating glia undergo dramatic morphological changes to generate large, specialized membrane extensions that warp around the axon.  These substantial morphological changes require extensive reorganization of the cytoskeleton.  We are studying the role of cytoskeletal adaptor proteins which link extracellular signals to the intracellular machinery that controls myelin formation.

    Organization of myelinated axons

    The physiology of myelinated nerves depends on the organization of the axonal membrane into distinct domains which contain different ion channels.  This exquisite molecular organization of the axon is controlled by the overlying Schwann cells or oligodendrocyes.  We are using different molecular and genetic approaches to reveal how myelinating glia shapes the membrane of the axons they wrap.

    The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel, and Founder of the Institute.

    When Elior is not researching, teaching, traveling, or participating in Genesis Club initiatives, Ori (as he is also known) is an enthusiastic triathlete, so outside of the lab you can often find him swimming, cycling, and running.

    We are honored to have Professor Peles as a Member of the Club, especially given to his devotion to discovering and developing cellular-biology-based technologies that reduce suffering, and improve lives.